Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome.

about

Effectiveness of adherence to a preoperative antiplatelet and anticoagulation cessation protocol in cardiac surgery.The Effect of Admission Renal Function on the Treatment and Outcome of Patients with Acute Coronary Syndrome.

P2860

Q47197973-3E38FC1F-8451-4750-85C7-0D2370A2CA9D Q48714206-72CF653E-89E1-49AE-A4D2-0BFCDE005D14

P2860

Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome.

Item

http://www.wikidata.org/entity/Q41643200

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Characterising and predicting ...... th an acute coronary syndrome.

@en

type

Item

label

Characterising and predicting ...... th an acute coronary syndrome.

@en

prefLabel

Characterising and predicting ...... th an acute coronary syndrome.

@en

P1476

Characterising and predicting ...... th an acute coronary syndrome.

@en

P2093

Apixaban for Prevention of Acu ...... ng Committee and Investigators

http://www.w3.org/2001/XMLSchema#string

Danny Liaw

http://www.w3.org/2001/XMLSchema#string

Frank Cools

http://www.w3.org/2001/XMLSchema#string

John H Alexander

http://www.w3.org/2001/XMLSchema#string

Jose Lopez-Sendon

http://www.w3.org/2001/XMLSchema#string

Marcus Flather

http://www.w3.org/2001/XMLSchema#string

Megan L Neely

http://www.w3.org/2001/XMLSchema#string

Petr Jansky

http://www.w3.org/2001/XMLSchema#string

Rafael Diaz

http://www.w3.org/2001/XMLSchema#string

Razi Khan

http://www.w3.org/2001/XMLSchema#string

P2860

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Regis

Apixaban with antiplatelet therapy after acute coronary syndrome.

Rivaroxaban in patients with a recent acute coronary syndrome.

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

The association of cigarette smoking with enhanced platelet inhibition by clopidogrel.

Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.

P304

1475-1484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HEARTJNL-2014-307346

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26109589

http://www.w3.org/2001/XMLSchema#string

Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome.

about

P2860

P2860

Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698